These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23303495)

  • 21. Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis.
    Montanari S; Oliver A; Salerno P; Mena A; Bertoni G; Tümmler B; Cariani L; Conese M; Döring G; Bragonzi A
    Microbiology (Reading); 2007 May; 153(Pt 5):1445-1454. PubMed ID: 17464058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.
    Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A
    J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
    Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H
    Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.
    Clark ST; Sinha U; Zhang Y; Wang PW; Donaldson SL; Coburn B; Waters VJ; Yau YCW; Tullis DE; Guttman DS; Hwang DM
    Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
    Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A
    J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion.
    Maciá MD; Borrell N; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2665-72. PubMed ID: 15215124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
    Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
    BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis.
    Mulcahy LR; Burns JL; Lory S; Lewis K
    J Bacteriol; 2010 Dec; 192(23):6191-9. PubMed ID: 20935098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.
    Qin X; Zerr DM; McNutt MA; Berry JE; Burns JL; Kapur RP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5971-81. PubMed ID: 22964251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients.
    VanDevanter DR; Van Dalfsen JM; Burns JL; Mayer-Hamblett N
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):151-4. PubMed ID: 26407415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Comparative of Pseudomonas aeruginosa Small Colony Variant, Mucoid and Non-mucoid Phenotypes Obtained from a Patient with Cystic Fibrosis During Respiratory Exacerbations.
    Almeida MM; Bastos LR; Firmida MC; Albano RM; Marques EA; Leão RS
    Curr Microbiol; 2024 Jul; 81(9):274. PubMed ID: 39017880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.
    Oliver A; Cantón R; Campo P; Baquero F; Blázquez J
    Science; 2000 May; 288(5469):1251-4. PubMed ID: 10818002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
    Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
    Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
    Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
    Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
    PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.
    Warren AE; Boulianne-Larsen CM; Chandler CB; Chiotti K; Kroll E; Miller SR; Taddei F; Sermet-Gaudelus I; Ferroni A; McInnerney K; Franklin MJ; Rosenzweig F
    Infect Immun; 2011 Dec; 79(12):4802-18. PubMed ID: 21930755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
    Hogardt M; Hoboth C; Schmoldt S; Henke C; Bader L; Heesemann J
    J Infect Dis; 2007 Jan; 195(1):70-80. PubMed ID: 17152010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.